Medial Research Network


Stay up-to-date with the latest news and information from MRN about our involvement in helping fight COVID 19

Decentralized Clinical Trials Whitepaper

Running decentralized clinical trials is complex. Especially when "85% of all clinical trials fail to recruit enough patients, 80% are delayed due to recruitment problems" (, 2019) and the COVID19 pandemic resulted in "almost 53.5% of clinical trials being suspended." (Frost & Sullivan PB21-52 August 2020). We know it's not about making the complex simple, it's about making it happen efficiently and safely. To learn more read our new whitepaper below.

EVENT: CTE Virtual. Decentralized Clinical Trials - The Strategic Approach

Join us at CTE Virtual week, happening November 2-4, 2020. Our VP of Project Management and Head of US, Todd McGrath will be speaking on 'Decentralized Clinical Trials - The Strategic Approach'. This talk will look at what is the clinical trial landscape looking like, the impact of Covid-19, the key challenges facing clinical research, how DCT can help mitigate those challenges, when DCT should be used and how to best deliver DCT. Register to now and visit us at our virtual booth and attend Todd's talk to learn more.


Due to the number of questions and RFPs we are receiving, we have produced a series of FAQs to help you get to the information you want, quickly. Below, you'll find a variety of FAQs covering country coverage, ESU, HTS and supplies. Please continue to regularly check back with us as we'll be updating these as we receive more questions.

- Country Coverage FAQs

- Expedited Start-Up (ESU) FAQs

- General FAQs

- HTS Staff FAQs

- Supplies FAQs

International Responses to COVID 19

As a service to you, our colleagues, we've built a presentation comprised of the International Responses to COVID 19 from Europe, UK, North America and Australasia. It also covers guidance for GCP & Clinical Trials and PPE. We hope you find this helpful during these challenging times. This resource is updated every Tuesday so be sure to check back weekly for new information.

MRN Pandemic Response

An update from our CEO, Dr Graham Wylie

"We are the leading exponents of Home-based Clinical Trials.  We have the systems, processes, people and expertise.  To respond to the pandemic, we are accelerating our already rapid growth with even greater levels of recruitment and training."

Selecting the Right Support Systems for Home-Based Clinical Trials

As the leading experts in Home-based Clinical Trials, MRN are working closely with the companies leading the development of this exciting telemedicine field. To learn more about how MRNs Home Trial Support Services can help you successfully navigate through the labyrinth of moving your clinical trials further into the community please contact us using the button below or at